Idiopathic and Hereditary Pancreatitis
Chronic pancreatitis is characterized by persistent inflammation and progressive damage of the pancreas that eventually results in impairment of the exocrine and endocrine functions of the gland. Hereditary pancreatitis is defined as pancreatitis either with an autosomal dominant pattern of inheritance in two or more generations of a family or associated with a known disease-causing mutation. Age of onset is 10-14 years. Chronic pancreatitis is associated with a 26-fold increased incidence of pancreatic carcinoma.
Several known genetic mutations are associated with hereditary chronic pancreatitis. Cationic trypsinogen (also known as protease serine 1 or PRSS1) and the cystic fibrosis transmembrane conductance regulator (CFTR) genes, are among the most frequently identified alterations in subjects with Idiopathic and Hereditary Pancreatitis (IHP). Mutations in the chymotrypsinogen C and calcium sensing receptor genes are also considered lesser risk factors for this disease.
PRSS1 mutations causing pancreatitis are gain-of-function mutations that allow cationic trypsinogen to become activated to trypsin within the pancreas, as opposed to normally being activated in the duodenum. Two of the most common PRSS1 gene mutations (R122H and N29I) are reported to have a penetrance of 80 percent for hereditary pancreatitis. PRSS1 R122H mutation has been found in 10% of patients with idiopathic chronic or recurrent pancreatitis, and PRSS1 A16V mutation was found in 12% of children with chronic or hereditary pancreatitis. De novo PRSS1 mutations are found in up to 35 percent of those under age 25. Two other genes, SPINK1 (serine protease inhibitor Kazal type 1) and CFTR, are risk factors for pancreatitis. Mutations in SPINK1 and CFTR may be inherited in an autosomal recessive or multifactorial fashion.
Approximately 35 percent of individuals with idiopathic chronic pancreatitis have at least one CFTR mutation. The presence of two CFTR mutations increases the risk for idiopathic pancreatitis by 40 fold. Twenty-five percent of individuals with idiopathic chronic pancreatitis have homozygous SPINK1 mutations; persons with one copy of mutated SPINK1 have no increased risk. The SPINK1 mutation N34S increases the risk for pancreatitis by 14-fold. SPINK1 mutations do not appear to be increased in individuals with hereditary pancreatitis; furthermore, SPINK1 mutations do not appear to influence disease severity.
- Screening for patients with pancreatitis and family history of pancreatitis
- Diagnosis of hereditary pancreatitis in recurrent acute pancreatitis within the first two decades of life
- Treatment regimen and disease management
- The detection of a single gain-of-function PRSS1 mutation is causative for hereditary pancreatitis. Lack of detection of a mutation in PRSS1 does not eliminate a genetic etiology for hereditary pancreatitis
- The detection of a single deleterious CFTR or SPINK1 mutation increases the risk for pancreatitis, but is not causative for disease
- The detection of both a deleterious CFTR and SPINK1 mutation greatly increases the risk for chronic pancreatitis
- If two deleterious CFTR or SPINK1 mutations are detected in an affected individual, they are likely to be causative for pancreatitis. However, lack of detection of a mutation in PRSS1, SPINK1, or CFTR does not eliminate a genetic etiology for pancreatitis
No pathogenic variants (no mutations) detected in tested genes
Whole blood collected with anticoagulants, lavender (EDTA) top tube.
Stability
- Ambient: 3-5 days
- Refrigerated: 7-14 days
- Dig Dis. 2003;21(4):346-50. [PMID: 14752225]
- Dig Liver Dis. 2012 Sep 24. pii: S1590-8658(12)00297-6. [PMID: 23017645]
- J Intern Med. 2012 Aug;272(2):185-96. [PMID: 22239554]
- GeneReviews™ [Internet]. 2012 March 1. [PMID: 22379635]